Clinical Trial Update: Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ABT-335 in combination with atorvastatin to assess vascular wall thickening in patients with abnormal lipid levels, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Heart Disease
• Dyslipidemia

Drugs mentioned

• ABT-335
• Lipitor (atorvastatin)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Coronary Artery Disease, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-01-20